These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26471906)

  • 1. Intranasal oxytocin administration engenders blocked vasopressin homeostatic responses but no salivary vasopressin increases.
    Düsing R; Tops M; Quirin M
    Peptides; 2015 Dec; 74():70-1. PubMed ID: 26471906
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxytocin administration affects the production of multiple hormones.
    Weisman O; Feldman R
    Psychoneuroendocrinology; 2013 May; 38(5):626-7. PubMed ID: 23582729
    [No Abstract]   [Full Text] [Related]  

  • 3. Unitary hormonal models, peripheral markers, and evaluation of response to drug: a response to Weisman and Feldman.
    Guastella AJ; Alvares GA; Hickie IB; Chan HK; Chen TF; Banati RB
    Psychoneuroendocrinology; 2013 May; 38(5):627-8. PubMed ID: 23582730
    [No Abstract]   [Full Text] [Related]  

  • 4. Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research.
    Guastella AJ; Hickie IB; McGuinness MM; Otis M; Woods EA; Disinger HM; Chan HK; Chen TF; Banati RB
    Psychoneuroendocrinology; 2013 May; 38(5):612-25. PubMed ID: 23265311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary vasopressin increases following intranasal oxytocin administration.
    Weisman O; Schneiderman I; Zagoory-Sharon O; Feldman R
    Peptides; 2013 Feb; 40():99-103. PubMed ID: 23246527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.
    DeMayo MM; Song YJC; Hickie IB; Guastella AJ
    Paediatr Drugs; 2017 Oct; 19(5):391-410. PubMed ID: 28721467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.
    Quintana DS; Westlye LT; Rustan ØG; Tesli N; Poppy CL; Smevik H; Tesli M; Røine M; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2015 Jul; 5(7):e602. PubMed ID: 26171983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary levels of oxytocin remain elevated for more than two hours after intranasal oxytocin administration.
    Huffmeijer R; Alink LR; Tops M; Grewen KM; Light KC; Bakermans-Kranenburg MJ; Ijzendoorn MH
    Neuro Endocrinol Lett; 2012; 33(1):21-5. PubMed ID: 22467107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin, but not oxytocin, increases empathic concern among individuals who received higher levels of paternal warmth: A randomized controlled trial.
    Tabak BA; Meyer ML; Castle E; Dutcher JM; Irwin MR; Han JH; Lieberman MD; Eisenberger NI
    Psychoneuroendocrinology; 2015 Jan; 51():253-61. PubMed ID: 25462898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal oxytocin, but not vasopressin, augments neural responses to toddlers in human fathers.
    Li T; Chen X; Mascaro J; Haroon E; Rilling JK
    Horm Behav; 2017 Jul; 93():193-202. PubMed ID: 28161387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates.
    Galbusera A; De Felice A; Girardi S; Bassetto G; Maschietto M; Nishimori K; Chini B; Papaleo F; Vassanelli S; Gozzi A
    Neuropsychopharmacology; 2017 Jun; 42(7):1420-1434. PubMed ID: 27995932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Oxytocin and Vasopressin on Preferential Brain Responses to Negative Social Feedback.
    Gozzi M; Dashow EM; Thurm A; Swedo SE; Zink CF
    Neuropsychopharmacology; 2017 Jun; 42(7):1409-1419. PubMed ID: 27796303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.
    Guastella AJ; Ward PB; Hickie IB; Shahrestani S; Hodge MA; Scott EM; Langdon R
    Schizophr Res; 2015 Nov; 168(3):628-33. PubMed ID: 26150070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Oxytocin: Myths and Delusions.
    Leng G; Ludwig M
    Biol Psychiatry; 2016 Feb; 79(3):243-50. PubMed ID: 26049207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unaltered Oxytocin and Vasopressin Plasma Levels in Patients with Schizophrenia After 4 Months of Daily Treatment with Intranasal Oxytocin.
    Busnelli M; Dagani J; de Girolamo G; Balestrieri M; Pini S; Saviotti FM; Scocco P; Sisti D; Rocchi M; Chini B
    J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26715485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma oxytocin concentrations in man after different routes of administration of synthetic oxytocin.
    Landgraf R
    Exp Clin Endocrinol; 1985 Apr; 85(2):245-8. PubMed ID: 4018162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.
    Yatawara CJ; Einfeld SL; Hickie IB; Davenport TA; Guastella AJ
    Mol Psychiatry; 2016 Sep; 21(9):1225-31. PubMed ID: 26503762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal oxytocin attenuates the cortisol response to physical stress: a dose-response study.
    Cardoso C; Ellenbogen MA; Orlando MA; Bacon SL; Joober R
    Psychoneuroendocrinology; 2013 Mar; 38(3):399-407. PubMed ID: 22889586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine vasopressin and oxytocin modulate human social behavior.
    Ebstein RP; Israel S; Lerer E; Uzefovsky F; Shalev I; Gritsenko I; Riebold M; Salomon S; Yirmiya N
    Ann N Y Acad Sci; 2009 Jun; 1167():87-102. PubMed ID: 19580556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal oxytocin administration is reflected in human saliva.
    Weisman O; Zagoory-Sharon O; Feldman R
    Psychoneuroendocrinology; 2012 Sep; 37(9):1582-6. PubMed ID: 22436536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.